Latest Updates on Minimal Residual Disease (MRD)
Minimal residual disease (MRD) refers to the small number of myeloma cells that may remain in the body after treatment. Drs. Fonseca and Shah will outline data describing the use of MRD in clinical trials and what you need to discuss with your healthcare team.
During this event, you will:
- Hear how minimal residual disease is measured
- Listen to the experts discuss the science supporting the importance of achieving negative MRD status
- Learn how MRD measurement may be used for future monitoring of how effective a treatment is
- Be able to send the experts your questions related to minimal residual disease